Skip to main content
OpenTrials

Clinical trial condition

Advanced or Metastatic Solid Tumors

Explore clinical trials studying Advanced or Metastatic Solid Tumors. Study availability and eligibility vary by location and protocol.

53 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Advanced or Metastatic Solid Tumors trial results

Recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT06752681

Conditions
Advanced or Metastatic Solid Tumors
Locations
  • Site: 001-058 New Haven, Connecticut, United States
  • Site: 001-064 Sarasota, Florida, United States
  • Site: 001-060 Avon, Indiana, United States
  • Site: 001-059 Grand Rapids, Michigan, United States
View Trial Details
Recruiting

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

NCT07205718

Conditions
Advanced or Metastatic Solid Tumors
Locations
  • UCLA Health-Santa Monica Cancer Care (Cancer Care - Santa Monica) Santa Monica, California, United States
  • Yale School of Medicine - Smilow Cancer Hospital - Center for Thoracic Cancers New Haven, Connecticut, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
  • Johns Hopkins Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

NCT05538130

Conditions
Advanced or Metastatic Solid Tumors, Brain Diseases, Brain Neoplasms, +41 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham - Phase I Clinical Trials Unit Birmingham, Alabama, United States
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
View all 83 locations
View Trial Details
Recruiting

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

NCT06395519

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, BRCA Mutation, +52 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 14 locations
View Trial Details
Recruiting

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

NCT06234397

Conditions
Advanced or Metastatic Solid Tumors
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • The START Center for Cancer Care - Midwest Grand Rapids, Michigan, United States
  • Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center Cincinnati, Ohio, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details
Recruiting

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

NCT05753722

Conditions
Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Mass General Cancer Center Boston, Massachusetts, United States
  • Providence Cancer Institute Franz Clinic Portland, Oregon, United States
View Trial Details

Related conditions